[PDF] Top 20 DEVELOPMENT AND EVALUATION OF BOSENTAN PULSINCAP FORMULATION FOR CONTROLLED RELEASE

... a controlled release Pulsincap dosage form of Bosentan for the treatment of pulmonary arterial hypertension (PAH), which lead to serious cardiovascular ...complications. Bosentan is an ... See full document

... the development of CR formulations, in addition to the relationship between the rates of drug release from the delivery system to the maximum achievable rate of drug absorption in to the systemic ... See full document

... To determine the drug content and encapsulation efficiency of the beads, 10 mg beads were crushed using a porcelain mortar and a pestle, and dispersed in suitable solvent. The dispersion was sonicated for 15 minutes and ... See full document

... develop controlled release formulation of Glibenclamide to maintain constant therapeutic levels of the drug for over 10 ...physicochemical evaluation parameters and they were found to be ... See full document

... formulate controlled release matrix tablets of Bosentan. Bosentan is used to treat pulmonary arterial hypertension ...the development of ... See full document

... modified pulsincap technique to develop floating capsules of propranolol HCl using PEO WSR ...The formulation mixture was hand filled into the hardened body (formaldehyde exposed) and covered with ... See full document

... vitro Evaluation of Bosentan Osmotic Controlled Release Tablets” was ...formulate Bosentan as osmotic controlled release ...osmotic controlled release was ... See full document

... is controlled by a plug, which gets pushed away by swelling or erosion, and the drug is ...be controlled by manipulating the dimension and the position of the plug 5 ...Pulsatile release ... See full document

... blend formulation was selected for further fabrication of pulsatile ...drug release was controlled by the proportion of polymers ...vitro release studies of pulsatile device revealed that ... See full document

... formulate controlled release matrix tablets of Bosentan using HPMC K15M, HPMC E-15 and Xanthan gum are rate controlling polymer, PVP K-30 used as binder, microcrystalline cellulose as ...drug ... See full document

... acceptance and require lesser drug dosage. The other advantages of TDDS include increase in therapeutic efficacy and sustained plasma level of drug. The developments of TDDS involves selection of drug, evaluation ... See full document

... the formulation development and clinical testing; it is also an obstacle at the beginning when screening new compounds for pharmacological ...technological formulation approaches to make such poorly ... See full document

... modified pulsincap technology, for this the solubility of capsules was reduced by treating the capsules with cross-linking agent ...pre-formulation evaluation, mixture of drug-polymer, glidant and ... See full document

... Tablets were prepared by wet granulation technique. The composition of formulation is given in Table 11 .All the powders were passed through 80 mesh. Required quantities of drug and polymer were mixed thoroughly, ... See full document

... each formulation, the hardness and friability of 6 tablets were determined using the Monsanto hardness tester (Cad-mach, Ahmedabad, India) and the Roche friabilator (Camp- bell Electronics,Mumbai, India), ... See full document

... for controlled drug delivery is to alter the pharmacokinetic and pharmacokinetics of pharmacologically active moieties by using novel drug delivery systems or by modifying the molecular structure and or ... See full document

... sustained release matrix tablet of Glimepiride using tamrind gum as a release ...sustained release carrier. The pre-formulation studies of drug excipient mixtures were ...drug release, ... See full document

... formulated controlled release of propranolol hcl from chitosan-lactose-xanthan gum matrix ...for controlled propranolol HCL release prepared by direct compression was ...drug release ... See full document

... control release tablets are prepared by using excipients magnesium stearate, micro crystalline cellulose, lactose and polymers HPMC K-100M, HPMC E-5M ethyl cellulose, and Eudragit in different ratios ... See full document

... 2. The budesonide controlled release pellets were prepared by using different concentration of ethyl cellulose. But the optimized formula contains the matrix which was coated onto highly water soluble ... See full document